Back to All Events

Innovators Forum: Eclipse XL1’s Path to the First-in-Human Study

Eclipse XL1’s Path to the First-in-Human Study;  Andre Bessette, Chief Executive Officer at Eclipse  Regenesis Inc. and James Dunn, MD, PhD, Professor of Surgery and Bioengineering, Stanford School of Medicine